Company Overview

Company name: Elixinol Global (ASX: EXL)
Description: Operator of a holding company involved in industrial hemp and medicinal cannabis products. The company’s products include dietary supplements, skincare, hemp- derived food and medical products.
Year founded:
Parent company:
Industry: Healthcare | Group: Other Healthcare | Code:
Employees: 22
City: World Square
State: New South Wales
Country: Australia
Region: Oceania

Financial Highlights

Start up capital raised (USD Million): 15.88
Business status: Profitable
Ownership: Publicly Held
Exchange: ASX
Ticker: EXL
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2017
Financing Status: The received AUD 40 million of development capital from an undisclosed investor on September 28, 2018.
Number of active investors:
Profile last updated: 08-Oct-2018
Last known valuation: 81.72
Last known valuation date: 08-Jan-2018